{"id":"https://openalex.org/W2057718276","doi":"https://doi.org/10.1182/blood-2007-03-080689","title":"Nilotinib (formerly AMN107), a highly selective BCR-ABL tyrosine kinase inhibitor, is effective in patients with Philadelphia chromosome\u2013positive chronic myelogenous leukemia in chronic phase following imatinib resistance and intolerance","display_name":"Nilotinib (formerly AMN107), a highly selective BCR-ABL tyrosine kinase inhibitor, is effective in patients with Philadelphia chromosome\u2013positive chronic myelogenous leukemia in chronic phase following imatinib resistance and intolerance","publication_year":2007,"publication_date":"2007-08-22","ids":{"openalex":"https://openalex.org/W2057718276","doi":"https://doi.org/10.1182/blood-2007-03-080689","mag":"2057718276","pmid":"https://pubmed.ncbi.nlm.nih.gov/17715389"},"language":"en","primary_location":{"id":"doi:10.1182/blood-2007-03-080689","doi":"https://doi.org/10.1182/blood-2007-03-080689","is_oa":true,"landing_page_url":"https://doi.org/10.1182/blood-2007-03-080689","pdf_url":"https://ashpublications.org/blood/article-pdf/110/10/3540/1289667/zh802207003540.pdf","source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","datacite","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://ashpublications.org/blood/article-pdf/110/10/3540/1289667/zh802207003540.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5090435894","display_name":"Hagop M. Kantarjian","orcid":"https://orcid.org/0000-0002-1908-3307","observed_orcids":["https://orcid.org/0000-0002-1908-3307"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Hagop M. Kantarjian","raw_affiliation_strings":["M. D. Anderson Cancer Center, Houston, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"M. D. Anderson Cancer Center, Houston, TX;","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061285204","display_name":"Francis Joseph Giles","orcid":"https://orcid.org/0000-0002-6919-0231","observed_orcids":["https://orcid.org/0000-0002-6919-0231"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Francis Giles","raw_affiliation_strings":["M. D. Anderson Cancer Center, Houston, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"M. D. Anderson Cancer Center, Houston, TX;","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042020284","display_name":"Norbert Gattermann","orcid":"https://orcid.org/0000-0002-9792-2495","observed_orcids":["https://orcid.org/0000-0002-9792-2495"]},"institutions":[{"id":"https://openalex.org/I4210089242","display_name":"D\u00fcsseldorf University Hospital","ror":"https://ror.org/006k2kk72","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I4210089242"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Norbert Gattermann","raw_affiliation_strings":["Universitaetsklinikum Duesseldorf, Duesseldorf, Germany;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Universitaetsklinikum Duesseldorf, Duesseldorf, Germany;","institution_ids":["https://openalex.org/I4210089242"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079069209","display_name":"Kapil N. Bhalla","orcid":"https://orcid.org/0000-0001-5209-5126","observed_orcids":["https://orcid.org/0000-0001-5209-5126"]},"institutions":[{"id":"https://openalex.org/I3019308854","display_name":"Moffitt Cancer Center","ror":"https://ror.org/01xf75524","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I3019308854"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kapil Bhalla","raw_affiliation_strings":["H. Lee Moffitt Cancer Center, Tampa, FL;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"H. Lee Moffitt Cancer Center, Tampa, FL;","institution_ids":["https://openalex.org/I3019308854"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008958861","display_name":"Giuliana Alimena","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2800330116","display_name":"Policlinico Umberto I","ror":"https://ror.org/011cabk38","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I2800330116"]},{"id":"https://openalex.org/I861853513","display_name":"Sapienza University of Rome","ror":"https://ror.org/02be6w209","country_code":"IT","type":"education","lineage":["https://openalex.org/I861853513"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Giuliana Alimena","raw_affiliation_strings":["Azienda Policlinico Umberto I\u2013Universita La Sapienza, Rome, Italy;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Azienda Policlinico Umberto I\u2013Universita La Sapienza, Rome, Italy;","institution_ids":["https://openalex.org/I2800330116","https://openalex.org/I861853513"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002133396","display_name":"Francesca Palandri","orcid":"https://orcid.org/0000-0001-8367-5668","observed_orcids":["https://orcid.org/0000-0001-8367-5668"]},"institutions":[{"id":"https://openalex.org/I4210097083","display_name":"IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola","ror":"https://ror.org/00t4vnv68","country_code":"IT","type":"healthcare","lineage":["https://openalex.org/I4210097083"]},{"id":"https://openalex.org/I9360294","display_name":"University of Bologna","ror":"https://ror.org/01111rn36","country_code":"IT","type":"education","lineage":["https://openalex.org/I9360294"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Francesca Palandri","raw_affiliation_strings":["S. Orsola\u2013Malpighi University Hospital, University of Bologna, Bologna, Italy;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"S. Orsola\u2013Malpighi University Hospital, University of Bologna, Bologna, Italy;","institution_ids":["https://openalex.org/I4210097083","https://openalex.org/I9360294"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108882243","display_name":"Gert Jan Ossenkoppele","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I865915315","display_name":"Vrije Universiteit Amsterdam","ror":"https://ror.org/008xxew50","country_code":"NL","type":"education","lineage":["https://openalex.org/I865915315"]},{"id":"https://openalex.org/I911458345","display_name":"Amsterdam UMC Location Vrije Universiteit Amsterdam","ror":"https://ror.org/00q6h8f30","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I4210151833","https://openalex.org/I911458345"]}],"countries":["NL"],"is_corresponding":false,"raw_author_name":"Gert J. Ossenkoppele","raw_affiliation_strings":["Vrije University (VU) Medisch Centrum, Amsterdam, the Netherlands;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Vrije University (VU) Medisch Centrum, Amsterdam, the Netherlands;","institution_ids":["https://openalex.org/I865915315","https://openalex.org/I911458345"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082189560","display_name":"Franck Emmanuel Nicolini","orcid":"https://orcid.org/0000-0002-3192-4199","observed_orcids":["https://orcid.org/0000-0002-3192-4199","https://orcid.org/0000-0003-3779-1996","https://orcid.org/0000-0002-3499-5080"]},"institutions":[{"id":"https://openalex.org/I4210123600","display_name":"H\u00f4pital Edouard Herriot","ror":"https://ror.org/02qt1p572","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210100596","https://openalex.org/I4210123600"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"Franck-Emmanuel Nicolini","raw_affiliation_strings":["H\u00f3pital Edouard Herriot, Lyon, France;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"H\u00f3pital Edouard Herriot, Lyon, France;","institution_ids":["https://openalex.org/I4210123600"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5115589221","display_name":"Stephen G. O\u2019Brien","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2800516725","display_name":"Royal Victoria Infirmary","ror":"https://ror.org/01p19k166","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2800516725","https://openalex.org/I2801663869"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Stephen G. O'Brien","raw_affiliation_strings":["Royal Victoria Infirmary, Newcastle upon Tyne, United Kingdom;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Royal Victoria Infirmary, Newcastle upon Tyne, United Kingdom;","institution_ids":["https://openalex.org/I2800516725"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085360755","display_name":"Mark Robert Litzow","orcid":"https://orcid.org/0000-0002-9816-6302","observed_orcids":["https://orcid.org/0000-0002-9816-6302"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Mark Litzow","raw_affiliation_strings":["Mayo Clinic, College of Medicine, Rochester, MN;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mayo Clinic, College of Medicine, Rochester, MN;","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010061250","display_name":"Ravi Bhatia","orcid":"https://orcid.org/0000-0001-5740-2316","observed_orcids":["https://orcid.org/0000-0001-5740-2316"]},"institutions":[{"id":"https://openalex.org/I1301076528","display_name":"City Of Hope National Medical Center","ror":"https://ror.org/00w6g5w60","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1301076528"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ravi Bhatia","raw_affiliation_strings":["City of Hope National Medical Center, Duarte, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"City of Hope National Medical Center, Duarte, CA;","institution_ids":["https://openalex.org/I1301076528"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018111458","display_name":"Francisco Cervantes","orcid":"https://orcid.org/0000-0003-2664-8131","observed_orcids":["https://orcid.org/0000-0003-2664-8131"]},"institutions":[{"id":"https://openalex.org/I4210115097","display_name":"Hospital Cl\u00ednic de Barcelona","ror":"https://ror.org/02a2kzf50","country_code":"ES","type":"healthcare","lineage":["https://openalex.org/I4210115097"]}],"countries":["ES"],"is_corresponding":false,"raw_author_name":"Francisco Cervantes","raw_affiliation_strings":["Hospital Clinic, Barcelona, Spain;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hospital Clinic, Barcelona, Spain;","institution_ids":["https://openalex.org/I4210115097"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008647856","display_name":"Md Ariful Haque","orcid":"https://orcid.org/0000-0003-4632-5153","observed_orcids":["https://orcid.org/0000-0003-4632-5153"]},"institutions":[{"id":"https://openalex.org/I4210117619","display_name":"Novartis (United States)","ror":"https://ror.org/028fhxy95","country_code":"US","type":"company","lineage":["https://openalex.org/I1283582996","https://openalex.org/I4210117619"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ariful Haque","raw_affiliation_strings":["Novartis Pharmaceuticals, Florham Park, NJ;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis Pharmaceuticals, Florham Park, NJ;","institution_ids":["https://openalex.org/I4210117619"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108499479","display_name":"Yaping Shou","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117619","display_name":"Novartis (United States)","ror":"https://ror.org/028fhxy95","country_code":"US","type":"company","lineage":["https://openalex.org/I1283582996","https://openalex.org/I4210117619"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Yaping Shou","raw_affiliation_strings":["Novartis Pharmaceuticals, Florham Park, NJ;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis Pharmaceuticals, Florham Park, NJ;","institution_ids":["https://openalex.org/I4210117619"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061755998","display_name":"Debra J. Resta","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117619","display_name":"Novartis (United States)","ror":"https://ror.org/028fhxy95","country_code":"US","type":"company","lineage":["https://openalex.org/I1283582996","https://openalex.org/I4210117619"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Debra J. Resta","raw_affiliation_strings":["Novartis Pharmaceuticals, Florham Park, NJ;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis Pharmaceuticals, Florham Park, NJ;","institution_ids":["https://openalex.org/I4210117619"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5058408204","display_name":"Aaron Weitzman","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210117619","display_name":"Novartis (United States)","ror":"https://ror.org/028fhxy95","country_code":"US","type":"company","lineage":["https://openalex.org/I1283582996","https://openalex.org/I4210117619"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Aaron Weitzman","raw_affiliation_strings":["Novartis Pharmaceuticals, Florham Park, NJ;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Novartis Pharmaceuticals, Florham Park, NJ;","institution_ids":["https://openalex.org/I4210117619"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035964802","display_name":"Andreas Hochhaus","orcid":"https://orcid.org/0000-0003-0626-0834","observed_orcids":["https://orcid.org/0000-0003-0626-0834"]},"institutions":[{"id":"https://openalex.org/I223822909","display_name":"Heidelberg University","ror":"https://ror.org/038t36y30","country_code":"DE","type":"education","lineage":["https://openalex.org/I223822909"]},{"id":"https://openalex.org/I4387153978","display_name":"Medizinische Fakult\u00e4t Mannheim","ror":"https://ror.org/02m1z0a87","country_code":"DE","type":"education","lineage":["https://openalex.org/I4387153978"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Andreas Hochhaus","raw_affiliation_strings":["III Medizinische Klinik, Medizinische Fakult\u00e4t Mannheim, Universit\u00e4t Heidelberg, Mannheim, Germany; and"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"III Medizinische Klinik, Medizinische Fakult\u00e4t Mannheim, Universit\u00e4t Heidelberg, Mannheim, Germany; and","institution_ids":["https://openalex.org/I223822909","https://openalex.org/I4387153978"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5038582279","display_name":"Philipp le Coutre","orcid":"https://orcid.org/0000-0003-4532-1097","observed_orcids":["https://orcid.org/0000-0003-4532-1097"]},"institutions":[{"id":"https://openalex.org/I39343248","display_name":"Humboldt-Universit\u00e4t zu Berlin","ror":"https://ror.org/01hcx6992","country_code":"DE","type":"education","lineage":["https://openalex.org/I39343248"]},{"id":"https://openalex.org/I7877124","display_name":"Charit\u00e9 \u2013 Universit\u00e4tsmedizin Berlin","ror":"https://ror.org/001w7jn25","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I7877124"]}],"countries":["DE"],"is_corresponding":false,"raw_author_name":"Philipp le Coutre","raw_affiliation_strings":["Campus Virchow Klinikum, Charit\u00e9, Humboldt-Universit\u00e4t, Berlin, Germany","Campus Virchow Klinikum, Charite, Humboldt-Universitat, Berlin, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Campus Virchow Klinikum, Charit\u00e9, Humboldt-Universit\u00e4t, Berlin, Germany","institution_ids":["https://openalex.org/I39343248","https://openalex.org/I7877124"]},{"raw_affiliation_string":"Campus Virchow Klinikum, Charite, Humboldt-Universitat, Berlin, Germany","institution_ids":["https://openalex.org/I39343248","https://openalex.org/I7877124"]}]}],"institutions":[],"countries_distinct_count":7,"institutions_distinct_count":19,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":52.9691,"has_fulltext":true,"cited_by_count":748,"citation_normalized_percentile":{"value":0.99972232,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":99,"max":100},"biblio":{"volume":"110","issue":"10","first_page":"3540","last_page":"3546"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11215","display_name":"Chronic Myeloid Leukemia Treatments","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11215","display_name":"Chronic Myeloid Leukemia Treatments","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/nilotinib","display_name":"nilotinib","score":1.0},{"id":"https://openalex.org/keywords/bcr-abl-tyrosine-kinase-inhibitors","display_name":"BCR-ABL tyrosine kinase inhibitors","score":0.9509999752044678},{"id":"https://openalex.org/keywords/philadelphia-chromosome-positive-chronic-myeloid-leukemia","display_name":"Philadelphia chromosome-positive chronic myeloid leukemia","score":0.9480000138282776},{"id":"https://openalex.org/keywords/chronic-phase-cml","display_name":"chronic phase CML","score":0.8889999985694885},{"id":"https://openalex.org/keywords/imatinib-resistance","display_name":"imatinib resistance","score":0.9959999918937683},{"id":"https://openalex.org/keywords/imatinib-intolerance","display_name":"imatinib intolerance","score":0.9950000047683716},{"id":"https://openalex.org/keywords/bcr-abl-mutations","display_name":"BCR-ABL mutations","score":0.9039999842643738},{"id":"https://openalex.org/keywords/t315i-mutation","display_name":"T315I mutation","score":0.9309999942779541},{"id":"https://openalex.org/keywords/major-cytogenetic-response","display_name":"major cytogenetic response","score":0.9229999780654907},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.7979999780654907},{"id":"https://openalex.org/keywords/neutropenia","display_name":"neutropenia","score":0.902999997138977},{"id":"https://openalex.org/keywords/thrombocytopenia","display_name":"thrombocytopenia","score":0.9570000171661377},{"id":"https://openalex.org/keywords/pleural-effusion","display_name":"pleural effusion","score":0.7360000014305115},{"id":"https://openalex.org/keywords/pericardial-effusion","display_name":"pericardial effusion","score":0.8949999809265137}],"concepts":[{"id":"https://openalex.org/C2777413986","wikidata":"https://www.wikidata.org/wiki/Q412327","display_name":"Nilotinib","level":4,"score":0.9759679436683655},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7975478768348694},{"id":"https://openalex.org/C2777583451","wikidata":"https://www.wikidata.org/wiki/Q177094","display_name":"Imatinib","level":3,"score":0.7704452276229858},{"id":"https://openalex.org/C2776960273","wikidata":"https://www.wikidata.org/wiki/Q729735","display_name":"Chronic myelogenous leukemia","level":3,"score":0.6738017201423645},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6418291330337524},{"id":"https://openalex.org/C2778904597","wikidata":"https://www.wikidata.org/wiki/Q1129111","display_name":"Philadelphia chromosome","level":4,"score":0.5611945986747742},{"id":"https://openalex.org/C2778820342","wikidata":"https://www.wikidata.org/wiki/Q906415","display_name":"Tyrosine-kinase inhibitor","level":3,"score":0.5201119184494019},{"id":"https://openalex.org/C3019892230","wikidata":"https://www.wikidata.org/wiki/Q177094","display_name":"Imatinib mesylate","level":4,"score":0.4571400284767151},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.4322836399078369},{"id":"https://openalex.org/C42362537","wikidata":"https://www.wikidata.org/wiki/Q87099740","display_name":"Tyrosine kinase","level":3,"score":0.4250350892543793},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.4202282726764679},{"id":"https://openalex.org/C2778729363","wikidata":"https://www.wikidata.org/wiki/Q11688946","display_name":"Myeloid leukemia","level":2,"score":0.41204190254211426},{"id":"https://openalex.org/C2778461978","wikidata":"https://www.wikidata.org/wiki/Q29496","display_name":"Leukemia","level":2,"score":0.2896944284439087},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.09907281398773193},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.08049088716506958},{"id":"https://openalex.org/C138626823","wikidata":"https://www.wikidata.org/wiki/Q916504","display_name":"Chromosomal translocation","level":3,"score":0.06479150056838989},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000068877","descriptor_name":"Imatinib Mesylate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000970","descriptor_name":"Antineoplastic Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D001549","descriptor_name":"Benzamides","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002908","descriptor_name":"Chronic Disease","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010879","descriptor_name":"Piperazines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D010879","descriptor_name":"Piperazines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D011505","descriptor_name":"Protein-Tyrosine Kinases","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D011743","descriptor_name":"Pyrimidines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D015464","descriptor_name":"Leukemia, Myelogenous, Chronic, BCR-ABL Positive","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D016044","descriptor_name":"Fusion Proteins, bcr-abl","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019008","descriptor_name":"Drug Resistance, Neoplasm","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false}],"locations_count":5,"locations":[{"id":"doi:10.1182/blood-2007-03-080689","doi":"https://doi.org/10.1182/blood-2007-03-080689","is_oa":true,"landing_page_url":"https://doi.org/10.1182/blood-2007-03-080689","pdf_url":"https://ashpublications.org/blood/article-pdf/110/10/3540/1289667/zh802207003540.pdf","source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},{"id":"pmid:17715389","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17715389","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"Clinical Trial, Phase II"},{"id":"pmh:oai:iris.uniroma1.it:11573/31970","doi":null,"is_oa":false,"landing_page_url":"http://www.ncbi.nlm.nih.gov/pubmed/17715389","pdf_url":null,"source":{"id":"https://openalex.org/S4377196107","display_name":"IRIS Research product catalog (Sapienza University of Rome)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"info:eu-repo/semantics/article"},{"id":"doi:10.25405/ncl.34078908","doi":"https://doi.org/10.25405/ncl.34078908","is_oa":true,"landing_page_url":"https://doi.org/10.25405/ncl.34078908","pdf_url":null,"source":{"id":"https://openalex.org/S4306402485","display_name":"Newcastle University ePrints (Newcastle Univesity)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I84884186","host_organization_name":"Newcastle University","host_organization_lineage":["https://openalex.org/I84884186"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"JournalArticle"},{"id":"mag:3151598270","doi":null,"is_oa":false,"landing_page_url":"http://ci.nii.ac.jp/naid/20000901890","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"Blood","raw_type":null}],"best_oa_location":{"id":"doi:10.1182/blood-2007-03-080689","doi":"https://doi.org/10.1182/blood-2007-03-080689","is_oa":true,"landing_page_url":"https://doi.org/10.1182/blood-2007-03-080689","pdf_url":"https://ashpublications.org/blood/article-pdf/110/10/3540/1289667/zh802207003540.pdf","source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.98580002784729}],"study_designs":[{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2057718276.pdf","grobid_xml":"https://content.openalex.org/works/W2057718276.grobid-xml"},"referenced_works_count":25,"referenced_works":["https://openalex.org/W1994309500","https://openalex.org/W1995050303","https://openalex.org/W1998990808","https://openalex.org/W1999614615","https://openalex.org/W2006917576","https://openalex.org/W2010791052","https://openalex.org/W2011474502","https://openalex.org/W2012238745","https://openalex.org/W2028959752","https://openalex.org/W2039978091","https://openalex.org/W2054251966","https://openalex.org/W2076736727","https://openalex.org/W2080125373","https://openalex.org/W2092606584","https://openalex.org/W2097946794","https://openalex.org/W2106555552","https://openalex.org/W2107268345","https://openalex.org/W2120033838","https://openalex.org/W2124196948","https://openalex.org/W2126579741","https://openalex.org/W2134566943","https://openalex.org/W2264762610","https://openalex.org/W2314938037","https://openalex.org/W2532234056","https://openalex.org/W2556455286"],"related_works":["https://openalex.org/W2979395636","https://openalex.org/W3187843527","https://openalex.org/W2589955083","https://openalex.org/W2579504722","https://openalex.org/W2066099870","https://openalex.org/W2559459637","https://openalex.org/W2008442882","https://openalex.org/W2148010414","https://openalex.org/W2213416338","https://openalex.org/W2570460670"],"abstract_inverted_index":{"Nilotinib,":[0],"an":[1],"orally":[2,36],"bioavailable,":[3],"selective":[4],"Bcr-Abl":[5],"tyrosine":[6],"kinase":[7],"inhibitor,":[8],"is":[9,186,203],"30-fold":[10],"more":[11],"potent":[12],"than":[13],"imatinib":[14,21,54,129,196],"in":[15,49,102,109,122,135,168,178,191],"pre-clinical":[16],"models,":[17],"and":[18,66,71,79,104,133,152,164,189],"overcomes":[19],"most":[20],"resistant":[22],"BCR-ABL":[23,125,143],"mutations.":[24,144],"In":[25,183],"this":[26],"phase":[27,51],"2":[28],"open-label":[29],"study,":[30],"400":[31],"mg":[32],"nilotinib":[33,185],"was":[34,96,117,120,154],"administered":[35],"twice":[37],"daily":[38],"to":[39,150,161],"280":[40],"patients":[41,123,136,192],"with":[42,128,137,157,193],"Philadelphia":[43],"chromosome-positive":[44],"(Ph(+))":[45],"chronic":[46,50],"myeloid":[47],"leukemia":[48],"(CML-CP)":[52],"after":[53,195],"failure":[55,197],"or":[56,93,173,198],"intolerance.":[57,199],"Patients":[58],"had":[59],"at":[60,114,205],"least":[61],"6":[62,83],"months":[63,116],"of":[64,87,142,170],"follow-up":[65],"were":[67,147,166,176,181],"evaluated":[68],"for":[69,77],"hematologic":[70],"cytogenetic":[72,89],"responses,":[73],"as":[74,76,207],"well":[75],"safety":[78],"overall":[80],"survival.":[81],"At":[82],"months,":[84],"the":[85],"rate":[86],"major":[88],"response":[90],"(Ph":[91,99,106],"<":[92],"=":[94,100,107],"35%)":[95],"48%:":[97],"complete":[98],"0%)":[101],"31%,":[103],"partial":[105],"1%-35%)":[108],"16%.":[110],"The":[111],"estimated":[112],"survival":[113],"12":[115],"95%.":[118],"Nilotinib":[119],"effective":[121],"harboring":[124],"mutations":[126],"associated":[127],"resistance":[130,139],"(except":[131],"T315I),":[132],"also":[134],"a":[138],"mechanism":[140],"independent":[141],"Adverse":[145],"events":[146],"mostly":[148],"mild":[149],"moderate,":[151],"there":[153],"minimal":[155],"cross-intolerance":[156],"imatinib.":[158],"Grades":[159],"3":[160],"4":[162],"neutropenia":[163],"thrombocytopenia":[165],"observed":[167,177],"29%":[169],"patients;":[171],"pleural":[172],"pericardial":[174],"effusions":[175],"1%":[179],"(none":[180],"severe).":[182],"summary,":[184],"highly":[187],"active":[188],"safe":[190],"CML-CP":[194],"This":[200],"clinical":[201],"trial":[202],"registered":[204],"http://clinicaltrials.gov":[206],"ID":[208],"no.":[209],"NCT00109707.":[210]},"counts_by_year":[{"year":2026,"cited_by_count":8},{"year":2025,"cited_by_count":13},{"year":2024,"cited_by_count":9},{"year":2023,"cited_by_count":14},{"year":2022,"cited_by_count":14},{"year":2021,"cited_by_count":21},{"year":2020,"cited_by_count":13},{"year":2019,"cited_by_count":24},{"year":2018,"cited_by_count":30},{"year":2017,"cited_by_count":29},{"year":2016,"cited_by_count":35},{"year":2015,"cited_by_count":39},{"year":2014,"cited_by_count":42},{"year":2013,"cited_by_count":55},{"year":2012,"cited_by_count":60}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-06-24T00:00:00"}